To investigate a potential effect of NK alloreactivity as predicted by the missing ligand model in the setting of unrelated transplantation, we investigated 496 patients transplanted for malignant disorders with single HLA-B or HLA-C mismatched donors and T-cell-replete grafts. “Missing ligand” was defined as absence of a donor KIR ligand HLA-C group 1,2 or HLA-Bw4 allele in the patient in GvH-direction only or in combined HvG/GvH direction. Overall survival (OS), disease free survival (DFS), relapse, and treatment related mortality (TRM) were assessed using Kaplan-Meier analysis, competing risks regression and extended Cox regression models.
Out of the 496 transplantation pairs, 109 (22.0%) were identified as belonging to the “missing ligand“-group, the remaining 387 (78.0%) were used as a control group. Univariate and multivariate analysis did not show any differences regarding OS or DFS between the two groups. Univariate analysis showed no significant difference regarding TRM (31.6% vs. 21.1%, p=0.13) and a significant higher risk for relapse (29.0% vs. 38.7%, p=0.048) in the “missing ligand” group. Multivariate competing risks regression showed no significant difference for TRM (HR 0.76, CI 0.49-1.23, p=0.28) and a trend towards increased rates of relapse (HR 1.49, CI 1.00 – 2.20, p=0.05) for the patients within the “missing ligand” group.
The results of this study do not confirm previous results seen in haploidentical HSCT. T-cell alloreactivity dominates over NK cell alloreactivity and leads to a diminished reconstitution of KIR expression in T-cell-replete grafts and potentially impaired "licensing" compared to T-cell depleted transplantations. This effect could explain differences between the haploidentical related and single mismatched unrelated transplantation.
See more of: Contributed Abstracts